Discontinued — last reported Q4 '25

Other Investing

Investing

Johnson & Johnson Other Investing decreased by 8.3% to $33.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 106.3%, from $16.00M to $33.00M.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ4 2014
Last reportedQ4 2025

How to read this metric

Usually represents minor adjustments; however, large values should be scrutinized for one-time asset disposals or unusual investment activities.

Detailed definition

A category capturing miscellaneous cash flows from investing activities that do not fall under capital expenditures, acq...

Peer comparison

Standard across most corporate cash flow statements as a balancing category for non-core investing movements.

Metric ID: cf_other_investing

Historical Data

10 periods
 Q2 '21Q2 '22Q2 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$101.00M$59.00M$12.00M$5.00M$81.00M$16.00M$72.00M$30.00M$36.00M$33.00M
QoQ Change-41.6%-79.7%-58.3%>999%-80.2%+350.0%-58.3%+20.0%-8.3%
YoY Change-41.6%-79.7%+575.0%+500.0%-55.6%+106.3%
Range$5.00M$101.00M
CAGR-39.2%
Avg YoY Growth+167.4%
Median YoY Growth+32.3%

Frequently Asked Questions

What is Johnson & Johnson's other investing?
Johnson & Johnson (JNJ) reported other investing of $33.00M in Q3 2025.
How has Johnson & Johnson's other investing changed year-over-year?
Johnson & Johnson's other investing increased by 106.3% year-over-year, from $16.00M to $33.00M.
What does other investing mean?
Miscellaneous cash transactions related to long-term investments or asset sales not covered in other categories.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.